Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Metastatic Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00779311
What this trial is testing

A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Accelerated Community Oncology Research Network 8
Large-scale testing (Phase 3)UnknownNCT02024412
What this trial is testing

Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in mCRC

Who this might be right for
Colorectal Cancer
Tianjin Medical University Cancer Institute and Hospital 240
Large-scale testing (Phase 3)Looking for participantsNCT06958419
What this trial is testing

Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorectal Cancer (MODIFI-CRC)

Who this might be right for
Immune Checkpoint TherapyRadiotherapyMetastatic Colorectal Cancer (CRC)
Sixth Affiliated Hospital, Sun Yat-sen University 286
Large-scale testing (Phase 3)Active Not RecruitingNCT04230187
What this trial is testing

Bevacizumab Plus mFOLFOXIRI as First-line Treatment for Patients With Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Yanhong Deng 528
Not applicableStudy completedNCT01811108
What this trial is testing

Assessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) in Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Hellenic Oncology Research Group 670
Testing effectiveness (Phase 2)Ended earlyNCT00065117
What this trial is testing

Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal NeoplasmsMetastases, Neoplasm
AstraZeneca 180
Large-scale testing (Phase 3)Study completedNCT01228734
What this trial is testing

A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients

Who this might be right for
Metastatic Colorectal Cancer
Merck KGaA, Darmstadt, Germany 553
Testing effectiveness (Phase 2)Study completedNCT00479752
What this trial is testing

Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Central European Cooperative Oncology Group 151
Not applicableLooking for participantsNCT07263178
What this trial is testing

Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
Boryung Pharmaceutical Co., Ltd 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06176885
What this trial is testing

Efficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
yue junhan 36
Large-scale testing (Phase 3)UnknownNCT00337389
What this trial is testing

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Who this might be right for
Metastatic Colorectal CancerColon CancerRectal Cancer
Mast Therapeutics, Inc. 1,200
Testing effectiveness (Phase 2)Active Not RecruitingNCT06268015
What this trial is testing

Botensilimab and Balstilimab Optimization in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Nicholas DeVito, MD 16
Not applicableStudy completedNCT00724503
What this trial is testing

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaLiver Metastases
Sirtex Medical 530
Large-scale testing (Phase 3)Study completedNCT05625932
What this trial is testing

TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticThromboembolism
Galician Research Group on Digestive Tumors 232
Testing effectiveness (Phase 2)Study completedNCT02350530
What this trial is testing

FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 138
Early research (Phase 1)Study completedNCT02069704
What this trial is testing

Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
mAbxience Research S.L. 142
Large-scale testing (Phase 3)Study completedNCT00973609
What this trial is testing

Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)

Who this might be right for
Colorectal Neoplasms
AIO-Studien-gGmbH 853
Testing effectiveness (Phase 2)Study completedNCT00094809
What this trial is testing

Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer

Who this might be right for
Colon CancerColorectal CancerRectal Cancer
Amgen 252
Testing effectiveness (Phase 2)Study completedNCT01288339
What this trial is testing

Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 78
Not applicableStudy completedNCT02624895
What this trial is testing

ObservationaL Study on the Qol of RAS Wild-type mCRC Patients Receiving Anti-EGFR MAbs + FOLFOX or FOLFIRI as 1st Line

Who this might be right for
Metastatic Colorectal Cancer
Amgen 296
Next Page